Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Dermatofibroma history and symptoms
Introduction
Overview
Overview
The majority of patients with dermatofibroma are asymptomatic. Dermatofibroma mostly develops as a single slow growing lesion on an extremity. Traumatized lesion may cause pain, bleeding, itching, erosive changes,and ulceration. Multiple dermatofibromas is a rare variant of disease which mostly seen in patients with underlying systemic disorders.
History and Symptoms
History and Symptoms
- The majority of patients with dermatofibroma are asymptomatic. [1]
- Dermatofibroma mostly develops as a single slow growing lesion on an extremity.
- Traumatized lesion may cause:[2]
- Pain
- Bleeding
- Itching
- Erosive changes
- Ulceration
- Multiple dermatofibromas is a rare variant of disease which mostly seen in patients with underlying systemic disorders. [3][4][5][6][7][8][9][10]
References
References
- ↑ Lee, MiWoo; Lee, WooJin; Jung, JoonMin; Won, ChongHyun; Chang, SungEun; Choi, JeeHo; Moon, KeeChan (2015). “Clinical and histological patterns of dermatofibroma without gross skin surface change: A comparative study with conventional dermatofibroma”. Indian Journal of Dermatology, Venereology, and Leprology. 81 (3): 263. doi:10.4103/0378-6323.154795. ISSN 0378-6323.
- ↑ Bhattacharjee, Pradip; Umar, Saleem; Fatteh, Shokat (2005). “Multiple Eruptive Dermatofibromas Occurring in a Patient with Myelodysplastic Syndrome”. Acta Dermato-Venereologica. -1 (1): 1–1. doi:10.1080/00015550410024517. ISSN 0001-5555.
- ↑ I. Lu, P. R. Cohen & M. E. Grossman (1995). “Multiple dermatofibromas in a woman with HIV infection and systemic lupus erythematosus”. Journal of the American Academy of Dermatology. 32 (5 Pt 2): 901–903. doi:10.1016/0190-9622(95)91558-3. PMID 7722054.
- ↑ P. R. Cohen (1991). “Multiple dermatofibromas in patients with autoimmune disorders receiving immunosuppressive therapy”. International journal of dermatology. 30 (4): 266–270. PMID 2050454.
- ↑ Mayuri Tanaka, Toshihiko Hoashi, Naotaka Serizawa, Kyochika Okabe, Susumu Ichiyama, Rie Shinohara, Yoko Funasaka & Hidehisa Saeki (2017). “Multiple unilaterally localized dermatofibromas in a patient with Down syndrome”. The Journal of dermatology. 44 (9): 1074–1076. doi:10.1111/1346-8138.13625. PMID 27665731.
- ↑ J. Stainforth & M. J. Goodfield (1994). “Multiple dermatofibromata developing during pregnancy”. Clinical and experimental dermatology. 19 (1): 59–60. PMID 8313640.
- ↑ Yuichiro Tsunemi, Hironobu Ihn, Naoko Hattori, Hidehisa Saeki & Kunihiko Tamaki (2003). “Multiple eruptive dermatofibromas with CD34+ cells in a patient with hypertriglyceridemia”. Dermatology (Basel, Switzerland). 207 (3): 319–321. doi:10.1159/000073098. PMID 14571078.
- ↑ H. B. Bargman & I. Fefferman (1986). “Multiple dermatofibromas in a patient with myasthenia gravis treated with prednisone and cyclophosphamide”. Journal of the American Academy of Dermatology. 14 (2 Pt 2): 351–352. doi:10.1016/s0190-9622(86)70041-8. PMID 3950136.
- ↑ S. E. Chang, J. H. Choi, K. J. Sung, K. C. Moon & J. K. Koh (2000). “Multiple eruptive dermatofibromas occurring in a patient with acute myeloid leukaemia”. The British journal of dermatology. 142 (5): 1062–1063. doi:10.1046/j.1365-2133.2000.03508.x. PMID 10809884.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]